London-based healthtech startup thymia has raised €2.4 million during its seed funding round, EU-Startups reports. Austrian digital health fund Calm/Storm participated in the round, alongside the lead investor Kodori Ventures.
- Founded in 2020 by Emilia Molimpakis and Stefano Goria, thymia develops an online platform that empowers clinicians, so they can assess depression faster, more accurately, and objectively. To achieve that, the startup utilizes AI tools inside video games that analyse patients’ voices, facial expressions, movement, and behaviour.
- The startup’s seed round was led by Kodori Ventures, a private investment company in Switzerland, who was joined by the new and existing investors including Entrepreneur First, SyndicateRoom’s Access, and Form Ventures.
- Vienna-based early-stage VC fund Calm/Storm also participated in the funding as one of the existing investors. The fund invests in digital health, femtech, and tabootech, with a hard focus on female founders. In July 2023, the fund also backed Ada Growth, an Austrian microlearning platform.
- So far, thymia is already used for non-clinical mental wellness assessments. With the latest capital injection, the startup will scale the technology in the clinical space through medical device approval.
